drugset / Trial / NCT06239298
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a Multi-center, Open-labe, Phase I/II Study to evaluate the safety and tolerability of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor.
Timeline
- Start
- 2024-05-10
- Primary completion
- 2026-03
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donafenib | Small molecule | 0.1 g | Oral |
| Subject | Donafenib | Small molecule | 0.2 g | Oral |
| Subject | ZG005 | Unknown | — | Intravenous |